Background
The term "substance abuse," as used in this statement, includes those diseases described by the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) criteria as "psychoactive substance use disorders." 1 Psychoactive substances are abused primarily to depress, stimulate, or distort brain activity. Examples include alcohol, tobacco, "street" drugs (e.g., marijuana, lysergic acid diethylamide [LSD] , cocaine, methamphetamine, inhalants, methylenedioxymethamphetamine [MDMA] , gammahydroxybutyrate [GHB] , heroin, K2/Spice, salvia, bath salts), and the nonmedical use or the overuse of psychoactive and other prescription and nonprescription drugs (e.g., oxycodone, ketamine, methadone, dextromethorphan).
Substance abuse is a major societal problem. The 2011 National Household Survey on Drug Use and Health (NSDUH), a primary source of statistical information on drug abuse in the U.S. population, estimated that (a) 22.5 million Americans (or 8.7% of the population 12 years of age or older) had used an illicit drug* in the past month (b) 2.6 million Americans were classified with dependence or abuse of both illicit drugs and alcohol, (c) 3.9 million had dependence or abuse of illicit drugs but not alcohol, and (d) 14.1 million Americans were dependent on alcohol. 2 A study of psychiatric disorders in America suggested a lifetime prevalence of substance abuse disorders of 16.4%, of alcohol abuse or dependency of 13.3%, and of other drug abuse or dependency of 5.9%. 3 Studies suggest that the prevalence of drug abuse among health professionals appears to be similar to that in the general population. [4] [5] [6] Given their access, however, health professionals abuse prescription drugs more often and "street" drugs less often than does the general population.
Substance abuse frequently coexists with and complicates other psychiatric disorders, and it is a common and often unrecognized cause of physical morbidity. Intravenous drug abuse is a major factor in the spread of human immunodeficiency virus (HIV) and hepatitis. Alcohol is a major factor in cirrhosis of the liver, and tobacco is a key contributor to emphysema and lung cancer. Collectively, substance abuse contributes significantly to morbidity and mortality in our population and to the cost of health care.
Substance abuse is also a serious workplace problem. The 2010 NSDUH reported that approximately 13.3 million Americans reporting illicit drug use were currently employed full or part-time. 2 Substance abuse by employees of health care organizations leads to reduced productivity, increased absenteeism, drug diversion, and, almost certainly, increased accidents and medication misadventures. Consequently, it affects the quality of patient care, liability, and operational and health care costs.
The abuse, or non-medical use, of prescription medications has also become a prevalent issue. Nonmedical use of prescription drugs among youths aged 12 to 17 and young adults aged 18 to 25 in 2011 was the second most prevalent illicit drug use category, with marijuana being first. 2 The survey also found that over half of all prescription drug abusers had obtained the prescription medication "from a friend or relative for free" as compared to the 3.9% who had obtained the medication from a drug dealer or other stranger.
Pharmacists have unique, comprehensive knowledge about the safe and effective use of medications and about the adverse effects of their inappropriate use. The provision of pharmaceutical care to individual patients involves pharmacists assessing the appropriateness of pharmacotherapy, counseling, and monitoring medication-use outcomes. Health-system pharmacists have responsibilities for ensuring a safe and effective medication-use system, including legal and organizational responsibilities for medication distribution and control across the continuum of practice settings within health care organizations. With this combination of knowledge and organizational responsibilities, pharmacists are prepared to serve in leadership and service roles in substance abuse prevention and education and assist in a variety of patient care, employee health, and community activities.
Responsibilities
The scope of substance abuse responsibilities of pharmacists varies with the health care organization's mission, policies and procedures, patient population, and community. The responsibilities listed below should be adapted to meet local needs and circumstances. Each responsibility is intended to be applicable to any substance of abuse; therefore, specific substances are generally not mentioned. Pharmacists should be involved in substance abuse prevention, education, and assistance by performing the following activities: 2. Participating in public substance abuse education and prevention programs (e.g., in primary and secondary schools, colleges, churches, and civic organizations) and stressing the potential adverse health consequences of the misuse of legal and use of illegal drugs. 3. Opposing the sale of alcohol and tobacco products by pharmacists.
Establishing a multidisciplinary controlled-substance
inventory system, in compliance with statutory and regulatory requirements, that discourages diversion and enhances accountability. Where helpful, for example, procedures might require the purchase of controlled substances in tamper-evident containers and maintenance of a perpetual inventory and ongoing surveillance system. 5. Working with local, state, and federal authorities in controlling substance abuse, including participation in state prescription drug monitoring programs, encouraging participation in prescription disposal programs, complying with controlled-substance reporting regulations, and cooperating in investigations that involve the misuse of controlled substances, especially diversion from a health care organization. 6. Working with medical laboratories to (a) identify substances of abuse by using drug and poison control information systems, (b) establish proper specimen collection procedures based on knowledge of the pharmacokinetic properties of abused substances, and (c) select proper laboratory tests to detect the suspected substances of abuse and to detect tampering with samples. 7. Discouraging prescribing practices that enable or foster drug abuse behavior (e.g., prescribing a larger quantity of pain medication than is clinically needed for treatment of short-term pain).
Collaboration with outpatient and ambulatory care
providers to prevent substance abuse after discharge.
Education

1.
Providing information and referral to support groups appropriate to the needs of people whose lives are affected by their own or another person's substance abuse or dependency.
2.
Providing recommendations about the appropriate use of mood-altering substances to health care providers and the public, including those persons recovering from substance dependency and their caregivers. 
3.
Fostering the development of undergraduate and graduate college of pharmacy curricula and pharmacy technician education on the topic of substance abuse prevention, education, and assistance. 4. Providing substance abuse education to fellow pharmacists, other health care professionals, and other employees of their health care organization.
Instructing drug abuse counselors in drug treatment
programs about the pharmacology of abused substances and medications used for detoxification. 6. Promoting and providing alcohol risk-reduction education and activities. 7. Maintaining professional competency in substance abuse prevention, education, and assistance through formal and informal continuing education. 8. Conducting research on substance abuse and addiction. 9. Educating patients about the correct storage, handling, and proper disposal of prescription medications.
Assistance
1.
Assisting in the identification of patients, coworkers, and other individuals who may be having problems related to their substance abuse, and referring them to the appropriate people for evaluation and treatment.
Participating in multidisciplinary efforts to support
and care for the health care organization's employees and patients who are recovering from substance dependency. 3. Supporting and encouraging the recovery of health professionals with alcoholism or other drug addictions. Major elements of an employer's support program might include (a) a willingness to hire or retain employees; (b) participating in monitoring and reporting requirements associated with recovery or disciplinary contracts; (c) maintaining an environment supportive of recovery; (d) establishing behavioral standards and norms among all employees that discourage the abuse of psychoactive substances, including alcohol; and (e) participating in peer assistance programs. 4. Collaborating with other health care providers in the development of the pharmacotherapeutic elements of drug detoxification protocols. 5. Providing pharmaceutical care to patients being treated for substance abuse and dependency. 6. Maintaining knowledge of professional support groups (e.g., state-and national-level pharmacist recovery networks) and other local, state, and national organizations, programs, and resources available for preventing and treating substance abuse (see "Other Resources"). 7. Refusing to allow any student or employee, including health professionals, to work, practice, or be onsite for rotations within the health care organization while his or her ability to safely perform his or her responsibilities is impaired by drugs, including alcohol. The refusal should follow the organization's policies and procedures, the principles of ethical and responsible pharmacy practice, and statutory requirements. Practice should not be precluded after appropriate treatment and monitoring, if approved by the treatment provider or contract monitor (or both, when applicable).
